ATE399206T1 - Ribonukleoproteinkomplex aus paramyxovirus - Google Patents

Ribonukleoproteinkomplex aus paramyxovirus

Info

Publication number
ATE399206T1
ATE399206T1 AT00929790T AT00929790T ATE399206T1 AT E399206 T1 ATE399206 T1 AT E399206T1 AT 00929790 T AT00929790 T AT 00929790T AT 00929790 T AT00929790 T AT 00929790T AT E399206 T1 ATE399206 T1 AT E399206T1
Authority
AT
Austria
Prior art keywords
paramyxovirus
ribonucleoprotein complex
foreign gene
prepared
successfully
Prior art date
Application number
AT00929790T
Other languages
English (en)
Inventor
Kaio Kitazato
Tsugumine Shu
Hidekazu Kuma
Yasuji Ueda
Makoto Asakawa
Mamoru Hasegawa
Akihiro Iida
Takahiro Hirata
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Application granted granted Critical
Publication of ATE399206T1 publication Critical patent/ATE399206T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18822—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT00929790T 1999-05-18 2000-05-18 Ribonukleoproteinkomplex aus paramyxovirus ATE399206T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20074099 1999-05-18

Publications (1)

Publication Number Publication Date
ATE399206T1 true ATE399206T1 (de) 2008-07-15

Family

ID=16429391

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00929790T ATE399206T1 (de) 1999-05-18 2000-05-18 Ribonukleoproteinkomplex aus paramyxovirus

Country Status (12)

Country Link
EP (1) EP1179594B1 (de)
JP (1) JP3766596B2 (de)
KR (1) KR100686514B1 (de)
CN (1) CN100352925C (de)
AT (1) ATE399206T1 (de)
AU (1) AU4777900A (de)
CA (1) CA2368944C (de)
DE (1) DE60039292D1 (de)
DK (1) DK1179594T3 (de)
ES (1) ES2307509T3 (de)
HK (1) HK1044175B (de)
WO (1) WO2000070055A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000070070A1 (fr) * 1999-05-18 2000-11-23 Dnavec Research Inc. Vecteur de virus paramyxoviridae defectueux dans un gene enveloppe
US7226786B2 (en) 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
EP1251174A4 (de) * 2000-01-19 2003-05-02 Dnavec Research Inc Verwendung eines paramyxovirus-vektors für den gentransfer in blutgefässe
JP2002142770A (ja) 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
CN100357443C (zh) 2000-11-27 2007-12-26 株式会社载体研究所 编码血管生成基因的副粘病毒载体及其应用
US20070269414A1 (en) 2003-11-04 2007-11-22 Shinji Okano Method for Producing Gene Transferred Denritic Cells
CN1929867A (zh) 2004-01-13 2007-03-14 株式会社载体研究所 肿瘤的基因治疗，即利用编码免疫刺激性细胞因子的单链负链rna病毒载体进行的治疗
EP1717317A4 (de) 2004-01-22 2009-02-11 Dnavec Research Inc Verfahren zur herstellung viraler negativstrang-rna-vektoren unter verwendung eines den cytomegalovirus-enhancer und den beta-actin-promotor aus huhn umfassenden hybridpromotors
JPWO2006001120A1 (ja) 2004-06-24 2008-04-17 株式会社ディナベック研究所 マイナス鎖ｒｎａウイルスを含む抗癌剤
EP1916298B1 (de) 2005-06-14 2011-12-28 Dnavec Corporation Verfahren zur herstellung von monoklonalen antikörpern
WO2006137517A1 (ja) * 2005-06-24 2006-12-28 Dnavec Corporation 幼少個体への遺伝子導入用ベクター
CA2627485C (en) 2005-10-28 2017-02-21 Katsuyuki Mitomo Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with rna virus or dna virus spike protein
CA2636600A1 (en) 2006-01-17 2007-07-26 Dnavec Corporation Novel protein expression system
KR20090027693A (ko) 2006-05-31 2009-03-17 디나벡크 가부시키가이샤 알츠하이머병 치료제
KR20090114431A (ko) 2007-02-07 2009-11-03 디나벡크 가부시키가이샤 약독화 마이너스 가닥 ｒｎａ 바이러스
EP2143794A1 (de) 2007-04-27 2010-01-13 Kyushu University, National University Corporation Viraler vektor für gentherapie
EP2085479A1 (de) * 2008-01-31 2009-08-05 Institut Pasteur Reverse Genetik von Negativstrang-RNA-Viren in Hefe
EP2322611B1 (de) 2008-07-16 2016-06-01 IP Pharma Co., Ltd. Verfahren zur herstellung einer neuprogrammierten zelle anhand eines chromosomal unintegrierten virusvektors
WO2010050586A1 (ja) 2008-10-31 2010-05-06 ディナベック株式会社 組み換え蛋白質の発現を増強する方法
US8945576B2 (en) 2010-01-08 2015-02-03 Kyoto University Vaccine for treatment of tautopathy
AU2011241514A1 (en) 2010-04-16 2012-12-06 Dnavec Corporation Method for producing induced pluripotent stem cells
KR20130093624A (ko) 2010-08-30 2013-08-22 디나벡크 가부시키가이샤 다능성 줄기 세포를 유도하기 위한 조성물 및 그의 사용
EP2631290A4 (de) 2010-10-22 2015-06-10 Univ Hokkaido Nat Univ Corp Virusvektor für prime-boost-impfstoffe mit vacciniavirus-vektoren und sendaivirus-vektoren
WO2015046229A1 (ja) 2013-09-24 2015-04-02 ディナベック株式会社 多能性幹細胞の誘導効率を改善する方法
EP3542818A4 (de) 2016-11-17 2020-07-29 Japan as Represented by The Director-General of National Institute of Infectious Diseases Impfstoff gegen infektiöse krankheiten unter verwendung von nicht-infektiösen paramyxoviruspartikeln
AU2018302668A1 (en) * 2017-07-21 2020-02-06 I'rom Group Co., Ltd. Polynucleotide for modifying target sequence and use thereof
US20200353070A1 (en) 2018-01-22 2020-11-12 Japan As Represented By The Director-General Of National Institute Of Infectious Diseases Selective cd8-positive t cell-inducing vaccine antigen
US20230220025A1 (en) 2020-09-04 2023-07-13 Heartseed Inc. Quality Improving Agent for IPS Cells, Method of Producing IPS Cells, IPS Cells, and Composition for Producing IPS Cells
US20240060051A1 (en) 2020-12-25 2024-02-22 Kyoto University Method for Producing Naive Human IPS Cells From Somatic Cells
WO2023053220A1 (ja) 2021-09-28 2023-04-06 公益財団法人京都大学ｉＰＳ細胞研究財団 多能性幹細胞の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3992200B2 (ja) * 1995-11-01 2007-10-17 株式会社ディナベック研究所 組換え体センダイウイルスを利用した膜融合性リポソーム

Also Published As

Publication number Publication date
CA2368944A1 (en) 2000-11-23
KR100686514B1 (ko) 2007-02-23
ES2307509T3 (es) 2008-12-01
DE60039292D1 (de) 2008-08-07
DK1179594T3 (da) 2008-09-01
AU4777900A (en) 2000-12-05
CN1357044A (zh) 2002-07-03
KR20010113875A (ko) 2001-12-28
CA2368944C (en) 2010-07-27
EP1179594A4 (de) 2003-04-02
EP1179594A1 (de) 2002-02-13
JP3766596B2 (ja) 2006-04-12
HK1044175B (zh) 2008-11-14
HK1044175A1 (en) 2002-10-11
EP1179594B1 (de) 2008-06-25
WO2000070055A1 (fr) 2000-11-23
CN100352925C (zh) 2007-12-05

Similar Documents

Publication Publication Date Title
ATE399206T1 (de) Ribonukleoproteinkomplex aus paramyxovirus
NO990025L (no) Hamster-EF-1<alfa> transkripsjonsregulatorisk DNA
DE60038011D1 (de) Verbesserung der immunantwort als anwendung in impfstoff und gentherapie
ES2155702T4 (es) Construcciones expresivas halteroformes para la terapia genetica.
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
EA200500019A1 (ru) Ксиланазы, кодирующие их нуклеиновые кислоты и способы их получения и применения
EA200701450A1 (ru) РНКi МОДУЛЯЦИЯ RSV И ЕЁ ТЕРАПЕВТИЧЕСКОЕ ПРИМЕНЕНИЕ
EE200300100A (et) Polüpeptiid, selle kodeerivat nukleotiidjärjestust sisaldav nukleiinhape, vektor ja peremeesrakk, meetod polüpeptiidi valmistamiseks ning farmatseutiline kompositsioon
DE502006006865D1 (de) Neue dehydrogenasen, deren derivate und ein verfahren zur herstellung von optisch aktiven alkanolen
DK1117798T3 (da) Fungal transskriptionel aktivator egnet ved fremgangsmåder til produktion af polypeptider
MXPA03004767A (es) Genes de desarollo floral.
ATE310085T1 (de) Cyclin-e2 proteine und dafür kodierende gene
ATE450610T1 (de) Pflanzliche defensine
WO2002077158A3 (en) Root specific, stimulant inducible promoter and its use
DE502004006579D1 (de) L-carnitin dehydrogenasen, deren derivate und ein verfahren zur herstellung von substituierten (s)-alkanolen
ATE312169T1 (de) 5-aminolevulinsaure synthase aus aspergillus oryzae und dafuer kodierende nukleinsaeure
WO1999053075A3 (en) Cell cycle regulatory proteins cdc-16, dp-1, dp-2 and e2f from plants
WO2000068389A3 (en) Auxin transport proteins
DE122011100041I1 (de) In vitro-rekonstitution von segmentierten, negativstrang-rna-viren.
WO2000066743A3 (en) Viral expression vectors
DE60040077D1 (de) Vermehrungsproteine von pflanzen
WO2002083896A3 (en) Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
WO2003057824A3 (en) Compositions and methods for the inhibition of membrane fusion by paramyxoviruses
WO1999048486A3 (en) Plant cell cyclin genes
DE69940848D1 (de) (-)-strang rns virusvektor für nervenzellen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1179594

Country of ref document: EP

REN Ceased due to non-payment of the annual fee